Evidence map›Paper›PMID 31591307›Full record

ArticleJournal of fungi (Basel, Switzerland)2019

External Quality Assessment Evaluating the Ability of Dutch Clinical Microbiological Laboratories to Identify

Jochem B Buil, Henrich A L van der Lee, Ilse Curfs-Breuker, Paul E Verweij, Jacques F Meis

Abstract read
In one paragraph

Article in Journal of fungi (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Review
  3. Fast and Accurate Identification ofJournal of fungi (Basel, Switzerland) · 2023
    Article
  4. Review
  5. Diagnostic Allele-Specific PCR for the Identification ofJournal of fungi (Basel, Switzerland) · 2021
    Article
  6. Review
  7. Article
  8. Are We Ready for NosocomialFrontiers in cellular and infection microbiology · 2021
    Article
  9. Article
  10. Journal of fungi (Basel, Switzerland) · 2019
    Article
  11. Thermogenic Characterization and Antifungal Susceptibility ofJournal of fungi (Basel, Switzerland) · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jochem B BuilDepartment of Medical Microbiology, Radboud University Medical Center, 6525GA Nijmegen, The Netherlands. jochem.buil@radboudumc.nl.ORCID 0000-0003-4031-0778
Henrich A L van der LeeDepartment of Medical Microbiology, Radboud University Medical Center, 6525GA Nijmegen, The Netherlands. Henrich.vanderLee@radboudumc.nl.
Ilse Curfs-BreukerDepartment of Medical Microbiology, Radboud University Medical Center, 6525GA Nijmegen, The Netherlands. Ilse.Curfs-Breuker@radboudumc.nl.
Paul E VerweijDepartment of Medical Microbiology, Radboud University Medical Center, 6525GA Nijmegen, The Netherlands. paul.verweij@radboudumc.nl.
Jacques F MeisDepartment of Medical Microbiology, Radboud University Medical Center, 6525GA Nijmegen, The Netherlands. jacques.meis@gmail.com.ORCID 0000-0003-3253-6080

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background

methodsWe conducted an external quality assessment to evaluate the ability of Dutch clinical microbiological laboratories to identify

results35/47 participating laboratories were able to identify

conclusionsThere was a lack of awareness about the potential misidentification of

Indexed as

C. aurisMALDI-TOF MSmisidentification

Identifiers

PMID31591307
PMCPMC6958413

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.